Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betaseron 500 mcg vs 250 mcg in RRMS
NCT00893217Phase 2Completed
- Sponsor
- Bayer
- Start
- Nov 2002
- Modality
- Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon beta in relapsing-remitting multiple sclerosis (RRMS), sponsored by Bayer. Started Nov 2002; status: completed.
02
Drugs
interferon beta
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT00893217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00893217.